GlassScriptPhysician profile
Michael R Brown
NPI 1912007642
$4,221.18
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,851 · 2020: $162 · 2021: $314 · 2022: $351 · 2023: $25.60 · 2024: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $354 · Food and Beverage: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $353.89 |
| Food and Beverage | $190.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,474.21 | 2019 | |
| Zimmer Biomet Holdings, INC. | $466.33 | 2022-2024 | Advantagerib |
| Boston Scientific Corporation | $328.34 | 2019-2023 | Resonate El Icd Vr |
| Lemaitre Vascular, INC. | $148.15 | 2019-2021 | |
| Solventum Corporation | $126.88 | 2024 | Prevena |
| Astrazeneca Pharmaceuticals LP | $125.53 | 2020-2022 | |
| Medtronic, INC. | $122.41 | 2021 | |
| Edwards Lifesciences Corporation | $86.83 | 2020-2022 | |
| Amgen INC. | $72.46 | 2019 | |
| Pfizer INC. | $61.43 | 2019-2020 | |
| Innovation Technologies INC | $40.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $39.87 | 2020 | |
| Novartis Pharmaceuticals Corporation | $27.22 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $27.14 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $25.10 | 2019-2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $17.57 | 2019 | |
| Astellas Pharma US INC | $16.64 | 2019 | |
| W. L. Gore & Associates, INC. | $15.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.